Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Re-Transplantation, Higher Creatinine Levels in Hepatitis C Virus Patients, and Donor Age Are Predictors of Mortality in Long-Term Analysis of Late Acute Rejection in Liver Transplantation.

Nacif LS, Pinheiro RS, de Arruda Pécora RA, Tanigawa RY, Rocha-Santos V, Andraus W, Alves VA, D'Albuquerque LC.

Ann Transplant. 2017 Jan 10;22:9-16.

2.

Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.

García Bernardo CM, Argüelles García B, Redondo Buil P, Miyar de León A, González Dieguez L, Cadahía Rodrigo V, González-Pinto Arrillaga I, Vázquez Velasco L.

Transplant Proc. 2016 Nov;48(9):3006-3009. doi: 10.1016/j.transproceed.2016.07.047.

PMID:
27932132
3.

Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.

Czerwiński J, Lewandowska D, Małkowski P, Danielewicz R.

Transplant Proc. 2016 Jun;48(5):1347-9. doi: 10.1016/j.transproceed.2016.01.059.

PMID:
27496402
4.

Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.

Czerwiński J, Lewandowska D, Małkowski P, Danielewicz R.

Transplant Proc. 2016 Jun;48(5):1341-6. doi: 10.1016/j.transproceed.2016.01.058.

PMID:
27496401
5.

D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S.

Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090.

PMID:
27320548
6.

Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.

Burton CE, Doucette KE, Mabilangan CA, Plitt SS, Lee BE, Preiksaitis JK.

Transpl Infect Dis. 2016 Aug;18(4):520-8. doi: 10.1111/tid.12558. Epub 2016 Jul 29.

PMID:
27226204
7.

Liver Transplantation in India: At the Crossroads.

Nagral S, Nanavati A, Nagral A.

J Clin Exp Hepatol. 2015 Dec;5(4):329-40. doi: 10.1016/j.jceh.2015.11.001. Epub 2015 Nov 12. Review.

8.

Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.

Mueller JL, King LY, Johnson KB, Gao T, Nephew LD, Kothari D, Simpson MA, Zheng H, Wei L, Corey KE, Misdraji J, Lee JH, Lin MV, Gogela NA, Fuchs BC, Tanabe KK, Gordon FD, Curry MP, Chung RT.

Clin Transplant. 2016 Apr;30(4):452-60. doi: 10.1111/ctr.12710. Epub 2016 Mar 1.

9.

Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors.

Nemes B, Gámán G, Polak WG, Gelley F, Hara T, Ono S, Baimakhanov Z, Piros L, Eguchi S.

Expert Rev Gastroenterol Hepatol. 2016 Jul;10(7):827-39. doi: 10.1586/17474124.2016.1149061. Epub 2016 Mar 3. Review.

PMID:
26838962
10.

Liver Transplant Outcomes in a Newly Started Program.

Sultanaliev T, Zhexembayev A, Mukazhanov A, Zharkymbekov B, Kuttymuratov G, Spatayev Z, Ibrayev B, Yesmembetov K, Ashimkhanova A, Asykbayev M.

Exp Clin Transplant. 2015 Nov;13 Suppl 3:120-2.

11.

Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.

Ofosu A, Durand CM, Saberi B, Alqahtani S, Ucbilek E, Belden M, Cameron AM, Gurakar A.

Exp Clin Transplant. 2015 Nov;13 Suppl 3:7-10.

12.

The Long-Term Effect of Hepatitis C Virus on the Outcome of Live-Donor Kidney Transplant Recipients. A Retrospective Study.

Denewar AA, Monem El-Hendy YA, Wafa EW, Ghorab AA, Sheashaa HA, Rashad RH, Nagib AM, Neamatallah AH, Abbas MH, Shokeir AA.

Exp Clin Transplant. 2015 Oct;13(5):402-7.

13.

Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation.

Saigal S, Choudhary NS, Saraf N, Gautam D, Lipi L, Rastogi A, Goja S, Menon PB, Bhangui P, Ramachandra SK, Soin AS.

Indian J Gastroenterol. 2015 Jul;34(4):305-9. doi: 10.1007/s12664-015-0578-z. Epub 2015 Sep 23.

PMID:
26394853
14.

Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.

Coilly A, Samuel D.

J Hepatol. 2016 Jan;64(1):226-31. doi: 10.1016/j.jhep.2015.09.002. Epub 2015 Sep 12.

PMID:
26375245
15.

Hepatitis C virus infection in nonliver solid organ transplant candidates and recipients.

Aqel BA, Vargas HE.

Curr Opin Organ Transplant. 2015 Jun;20(3):259-66. doi: 10.1097/MOT.0000000000000195. Review.

PMID:
25944237
16.
17.

Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.

Yamamoto T, Tanaka S, Uenishi T, Kanazawa A, Kubo S, Hirohashi K.

Osaka City Med J. 2014 Dec;60(2):95-100.

PMID:
25803885
18.

Association of 49245A>G (rs868) polymorphism in the 3'UTR of donor TGFBR1 gene with course of hepatitis C following orthotopic liver transplantation.

Ziarkiewicz-Wróblewska B, Sajjad E, Ciszek M, Hutnik Ł, Łukasik D, Fedorowicz M, Wróblewski T, Patkowski W, Pączek L, Płoski R, Włodarski P, Malejczyk J.

Ann Transplant. 2014 Dec 12;19:643-51. doi: 10.12659/AOT.891119.

19.

[Activity and results of liver transplantation in Spain during 1984-2012. Analysis of the Spanish Liver Transplant Registry].

Cuervas-Mons V, de la Rosa G, Pardo F, San Juan F, Valdivieso A; en representación del Registro Español de Trasplante Hepático.

Med Clin (Barc). 2015 Apr 20;144(8):337-47. doi: 10.1016/j.medcli.2014.07.036. Epub 2014 Nov 13. Spanish.

PMID:
25458515
20.

Limits for adult liver donation in Spain.

Briceño J, Ciria R.

Transplant Proc. 2014 Nov;46(9):3079-81. doi: 10.1016/j.transproceed.2014.09.172. Review.

PMID:
25420827

Supplemental Content

Loading ...
Support Center